COMP <GO>
HRI vs TMO // NET PROFIT MARGIN
Herc Holdings Inc. Common Stock (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: HRI 5
— TMO 9
▲ NET PROFIT MARGIN LEADER: TMO
LAST: $165.76 (-4.71%) • MKT CAP: $5.82B
net-margins
0.10%
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
net-margins
15.10%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HRI VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HRI | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 41.00% | 0.00 | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 0.00% | 9.30% | -9.30 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation | 79.7x | 30.4x | +49.30 | TMO | /valuation <GO> |
| Free Cash Flow Yield | 15.94% | 2.40% | +13.54 | HRI | /fcf-yield <GO> |
| Operating Margin | 0.10% | 17.40% | -17.30 | TMO | /operating-margins <GO> |
| Net Profit Margin ACTIVE | 0.10% | 15.10% | -15.00 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 45.60% | 3.90% | +41.70 | HRI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.49% | 0.24% | +1.25 | HRI | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.45 | 4.50 | -4.05 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.80% | 6.70% | +0.10 | TMO | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 66.9 | 59.1 | +7.75 | HRI | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.97 | 0.94 | +0.03 | HRI | /macro-sensitivity <GO> |
| Forward P/E Multiple | 140.0x | 36.3x | +103.70 | TMO | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.82B | $262.22B | -$256.40B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HRI REV | TMO REV | HRI GROSS % | TMO GROSS % | HRI FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $862.0M | $44.56B | 44.0% | 44.0% | $928.0M | $6.29B |
| FY 2024 | $592.0M | $42.88B | 44.0% | 44.0% | $1.06B | $7.27B |
| FY 2023 | $600.0M | $42.86B | 44.0% | 44.0% | $1.06B | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HRI // BETA 0.97
TMO // BETA 0.94